TATVANSETatva Chintan Pharma Chem Limited· Chemicals & PetrochemicalsHighNeutral
Announced Fri, 31 Oct, 2025 · 15:44 IST

September 2025 results: six-month revenue up 27%, profit after tax up 282%

Revenue Growth 20pctRevenue DeclinePat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing

TATVA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.5%Reaction day
₹1433.00
prior close
₹1455.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-2.5% vs market
Specialty Chemicals peers, median of 85sector+0.5%-1.9% vs sector

On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 1.9 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.4
10m
-4.7
15m
-3.8
30m
-4.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.5+1.1-2.5+0.5-1.9
Next day
+6.8+0.3+6.5-0.2+7.0
2d
+1.5-1.4+2.9-1.5+3.1
3d
+5.0-1.0+6.0-1.8+6.8
4d
+3.3-1.4+4.7-2.3+5.6
5d
+3.3-1.6+4.9-3.6+6.9
1w
+3.1-0.8+3.9-2.9+6.0
15d
+1.8-3.6+5.4-7.9+9.7
1m
+0.3-4.0+4.4-8.4+8.8
2m
-6.7-3.9-2.8-8.1+1.4
3m
-12.4-8.4-4.0-14.0+1.5
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated revenue for the six months ended 30 September 2025 was Rs 240.38 crore, up 27.2% year on year from Rs 188.95 crore. Profit after tax rose to Rs 16.57 crore from Rs 4.34 crore, while operating cash flow was Rs 13.38 crore. Quarter revenue was nearly flat at Rs 123.52 crore versus Rs 124.52 crore. The auditor reported no material issues, and Ajesh Kumar Mohanan Pillai was appointed chief financial officer.

Likely market impact

Strong six-month profit growth and positive cash flow are positive, though nearly flat quarterly revenue may limit near-term stock price gains.